Vaccines made in South Africa to stay in Africa, says envoy

KAMPALA, Uganda (AP) — Vaccine doses produced by a plant in South Africa will no longer be exported to Europe following the intervention of South Africa's government, the African Union's COVID-19 vaccine envoy said Thursday.

South African drug manufacturer Aspen Pharmacare, which has a contract with Johnson & Johnson to assemble the ingredients of its COVID-19 vaccine, will produce for the African continent and millions of doses that had been shipped to European countries but remain in warehouses will be returned, Strive Masiyiwa told reporters.

J&J doses produced in South Africa “will stay in Africa and will be distributed in Africa,” he said at an online press briefing for the Africa Centers for Disease Control and Prevention.

The arrangement for some doses finished in South Africa to be exported to Europe “has been suspended,” he said, adding that the issue was “corrected in a positive way.”

Aspen's agreement with Johnson & Johnson has changed from a contract deal to “a licensed arrangement” similar to the production in India of the AstraZeneca vaccine.

The Aspen product will be “African branded,” he said.

Johnson & Johnson was heavily criticised for shipping doses to countries in Europe, which have already immunised large numbers of their people and have even donated vaccines to more needy countries.

In contrast, Africa has fully vaccinated less than 3% of its 1.3 billion people.

Vaccine production within the continent is seen as key to meeting the stated target of vaccinating 60% of Africa's population.

Half of those doses are expected to be procured under a vaccine acquisition group backed by the African Union that has already ordered 400 million J&J doses.

Under that deal, in which doses will be distributed across the continent over 12 months, 6.4 million doses were shipped in August and the number could rise to 20 million in September, according to Masiyiwa, coordinator of the African Union group known as the African Vaccine Acquisition Trust.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.